← Back to catalogue
t:connect Mobile Application, Mobile Bolus Enabled (Android)
FDA UDIClass II (US FDA UDI)
Identity
- Trade Name
- t:connect Mobile Application, Mobile Bolus Enabled (Android) FDA UDI
- Generic Name
- Ambulatory insulin infusion pump software, data-display FDA UDI
- Device Name
- t:connect Mobile Application, Mobile Bolus Enabled, 2.x (Android) FDA UDI
- Model / Reference
- 1007112 FDA UDI
- Description
- t:connect Mobile Application, Mobile Bolus Enabled, 2.x (Android) FDA UDI
Identifiers
- Primary DI / UDI-DI
- 90850018992445 FDA UDI
- FDA Product Code
- PJT FDA UDIQFG FDA UDI
- GMDN Term
- Ambulatory insulin infusion pump software, data-display FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.1350 FDA UDI880.5730 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Ambulatory insulin infusion pump software, data-displayAmbulatory insulin infusion pump remote control
t:connect Mobile Application, Mobile Bolus Enabled (Android) by Tandem Diabetes Care, Inc. — Class II — FDA UDI — listed in FDA GUDID
Similar devices
Also classified as Ambulatory insulin infusion pump remote control.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Tandem Diabetes Care, Inc.
Sources (1)
- FDA UDI cd672e31-31da-46e3-9709-b70f18653842 34 fields · synced Jun 8, 2026